These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2537368)

  • 1. Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat.
    Jessop DS; Eckland DJ; Todd K; Lightman SL
    J Endocrinol; 1989 Jan; 120(1):119-24. PubMed ID: 2537368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic regulation of methionine enkephalin in the posterior pituitary of the rat.
    Jessop D; Sidhu R; Lightman SL
    Brain Res; 1990 May; 516(1):41-5. PubMed ID: 2364280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat corticotropin-releasing factor and adrenocorticotropin secretion by an osmotic stimulus.
    Jessop DS; Chowdrey HS; Lightman SL
    Brain Res; 1990 Jul; 523(1):1-4. PubMed ID: 2169961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocinergic neurons in rat hypothalamus. Dexamethasone-reversible increase in their corticotropin-releasing factor-41-like immunoreactivity in response to osmotic stimulation.
    Dohanics J; Kovacs KJ; Makara GB
    Neuroendocrinology; 1990 May; 51(5):515-22. PubMed ID: 2112729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive corticotropin-releasing factor in rat plasma.
    Sumitomo T; Suda T; Tomori N; Yajima F; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Effects of Glucocorticoids on Corticotrophin-Releasing Factor in the Rat Pituitary Neurointermediate Lobe and Median Eminence.
    Jessop DS; Chowdrey HS; Lightman SL
    Eur J Neurosci; 1990 Jan; 2(1):109-111. PubMed ID: 12106109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic cocaine- and amphetamine-regulated transcript and corticotrophin releasing factor neurons are stimulated by extracellular volume and osmotic changes.
    Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J; Llewellyn-Smith IJ
    Neuroscience; 2011 Jul; 186():57-64. PubMed ID: 21539900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotic stimulation affects neurohypophysial corticotropin releasing factor-41 content: effect of dexamethasone.
    Dohanics J; Linton EA; Lowry PJ; Makara GB
    Peptides; 1990; 11(1):51-7. PubMed ID: 2342990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity.
    Berkenbosch F; Tilders FJ
    Brain Res; 1988 Mar; 442(2):312-20. PubMed ID: 2453250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress.
    Hannibal J; Mikkelsen JD; Fahrenkrug J; Larsen PJ
    Endocrinology; 1995 Sep; 136(9):4116-24. PubMed ID: 7649120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and modulation of corticotropin-releasing factor in the neurointermediate pituitary gland.
    Jeandel L; Van Dorsselaer A; Lutz-Bucher B; Koch B
    Neuroendocrinology; 1987 Feb; 45(2):146-51. PubMed ID: 3033535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei.
    Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T
    Neuroendocrinology; 1982 Jan; 34(1):32-7. PubMed ID: 6977102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing factor distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals.
    Krieger DT; Liotta A; Brownstein MJ
    Endocrinology; 1977 Jan; 100(1):227-37. PubMed ID: 11988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
    Dakine N; Oliver C; Grino M
    Life Sci; 2000 Oct; 67(23):2827-44. PubMed ID: 11105998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals.
    Lee S; Schmidt D; Tilders F; Cole M; Smith A; Rivier C
    Alcohol Clin Exp Res; 2000 Jan; 24(1):110-22. PubMed ID: 10656200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.
    Buckingham JC
    Eur J Pharmacol; 1984 Feb; 98(2):211-21. PubMed ID: 6325216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic regulation of substance P and neurokinin A peptide content and substance P binding sites in distinct hypothalamic nuclei of the rat.
    Larsen PJ; Jessop DS; Chowdrey HS; Mikkelsen JD; Lightman SL
    Peptides; 1992; 13(4):705-12. PubMed ID: 1279630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.